Skip to content
DataLookout
Menu

GENE-MAVNCT04772963

Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 10 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 10 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Mar 2026 to Feb 2027
    • Eligibility criteria expanded, about 2 words
  2. Minor Study completion date: Oct 2026 to Mar 2027v10
  3. Notable Primary completion date: Oct 2024 to Mar 2026v9
  4. Minor Study description expanded, about 239 wordsv8
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 2022 to Feb 17, 2022
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Oct 2021 to Feb 2022v5
  2. Notable Start date: Aug 2021 to Oct 2021
    • Primary completion date: Aug 2024 to Oct 2024
    • Study completion date: Aug 2026 to Oct 2026
    v4
  3. Notable Start date: Apr 2021 to Aug 2021
    • Primary completion date: Apr 2024 to Aug 2024
    • Study completion date: Apr 2026 to Aug 2026
    v3
  4. Minor Study title shortened, about 12 wordsv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Genetic mutation
Timeframe: limit of 12 month

Arms and interventions

Genetic: blood sample

Sites

1 site in 1 country

  • HOPITAL FONDATION Adolphe de ROTHSCHILDParis, France